Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Apremilast and Moderate to Severe Chronic Hand Dermatitis (CHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03741933
Recruitment Status : Not yet recruiting
First Posted : November 15, 2018
Last Update Posted : January 18, 2019
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Alison Ehrlich, George Washington University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : March 2020
Publications:
Berg S. Prävalenz von Handekzemen in Heidelberg und weltweit - die Heidelberger Prävalenzstudie im Vergleich mit Ergebnissen aus der Literatur. Dissertation, Heidelberg, 2005